TEVA
Teva Pharma Industries Ltd
39.20$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.1% | +11.5% | +2.2% | -15.8% | -10.4% | -1.4% | -4.7% | -6.0% | +6.2% | +4.4% | +4.3% | |
| – | -10.0% | +21.1% | +15.1% | -8.7% | -11.4% | -4.5% | -7.3% | -4.0% | +3.1% | +3.4% | -1.9% | |
| – | +2.7% | +4.4% | -8.7% | -23.4% | -9.2% | +2.5% | -1.7% | -8.2% | +9.6% | +5.5% | +10.9% | |
| – | +2.5% | +38.4% | -12.5% | -34.4% | -16.7% | +77.6% | -39.0% | -23.4% | +13.7% | +10.7% | -4.0% | |
| – | +1.8% | -0.2% | +7.6% | -2.4% | -8.2% | -1.6% | -6.3% | +7.4% | -1.5% | -0.1% | +10.9% | |
| – | -4.9% | +15.5% | -5.2% | -20.6% | +47.0% | +41.6% | -48.0% | +56.0% | -51.5% | +88.0% | -19.0% | |
| – | -15.2% | -35.7% | -911.7% | – | – | – | – | -228.0% | – | -170.0% | – | |
| – | +68.5% | +186.0% | -32.7% | -1.6% | +8.6% | -21.1% | +18.0% | +4.4% | +10.6% | -8.6% | -2.7% | |
| – | -35.3% | -65.0% | -2,330.5% | – | – | – | – | -571.1% | – | – | – | |
| – | +7.3% | -17.8% | -471.0% | – | – | -39.6% | +25.6% | -404.7% | – | – | -126.6% | |
| – | -48.0% | -79.3% | -5,043.8% | – | – | – | – | -686.6% | – | – | – | |
| – | +6.1% | -54.8% | -641.4% | – | +2,286.0% | +3.9% | -4.4% | -121.0% | – | +923.3% | -29.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.